These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Oral contraceptive use and the risk of epithelial ovarian cancer. La Vecchia C, Franceschi S, Decarli A. Br J Cancer; 1984 Jul 18; 50(1):31-4. PubMed ID: 6743513 [Abstract] [Full Text] [Related]
3. Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use. Petitti DB, Porterfield D. Contraception; 1992 Feb 18; 45(2):93-104. PubMed ID: 1559340 [Abstract] [Full Text] [Related]
4. The reduction in risk of ovarian cancer associated with oral-contraceptive use. Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development. N Engl J Med; 1987 Mar 12; 316(11):650-5. PubMed ID: 3821795 [Abstract] [Full Text] [Related]
5. Protection against endometrial carcinoma by combination-product oral contraceptives. Hulka BS, Chambless LE, Kaufman DG, Fowler WC, Greenberg BG. JAMA; 1987 Mar 12; 247(4):475-7. PubMed ID: 7033575 [Abstract] [Full Text] [Related]
6. Factors affecting the association of oral contraceptives and ovarian cancer. Cramer DW, Hutchison GB, Welch WR, Scully RE, Knapp RC. N Engl J Med; 1982 Oct 21; 307(17):1047-51. PubMed ID: 7121514 [Abstract] [Full Text] [Related]
7. Epithelial ovarian cancer and combined oral contraceptives. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Int J Epidemiol; 1989 Sep 21; 18(3):538-45. PubMed ID: 2807655 [Abstract] [Full Text] [Related]
8. Oral contraceptive use and the risk of ovarian cancer. The Centers for Disease Control Cancer and Steroid Hormone Study. JAMA; 1983 Mar 25; 249(12):1596-9. PubMed ID: 6338264 [Abstract] [Full Text] [Related]
10. The effects of oral contraceptives and parity on ovarian cancer trends in women under 55 years of age. Villard-Mackintosh L, Vessey MP, Jones L. Br J Obstet Gynaecol; 1989 Jul 25; 96(7):783-8. PubMed ID: 2788456 [Abstract] [Full Text] [Related]
12. A case-control study of oral contraceptive use and invasive epithelial ovarian cancer. Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Lewis JL, Strom BL, Harlap S, Shapiro S. Am J Epidemiol; 1994 Apr 01; 139(7):654-61. PubMed ID: 8166126 [Abstract] [Full Text] [Related]
13. Oral contraceptive use and mortality during 12 years of follow-up: the Nurses' Health Study. Colditz GA. Ann Intern Med; 1994 May 15; 120(10):821-6. PubMed ID: 8154642 [Abstract] [Full Text] [Related]
14. The risk of epithelial ovarian cancer in short-term users of oral contraceptives. Gross TP, Schlesselman JJ, Stadel BV, Yu W, Lee NC. Am J Epidemiol; 1992 Jul 01; 136(1):46-53. PubMed ID: 1415131 [Abstract] [Full Text] [Related]
15. Pooled analysis of 3 European case-control studies of epithelial ovarian cancer: III. Oral contraceptive use. Franceschi S, Parazzini F, Negri E, Booth M, La Vecchia C, Beral V, Tzonou A, Trichopoulos D. Int J Cancer; 1991 Aug 19; 49(1):61-5. PubMed ID: 1874572 [Abstract] [Full Text] [Related]
16. Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use. Wu ML, Whittemore AS, Paffenbarger RS, Sarles DL, Kampert JB, Grosser S, Jung DL, Ballon S, Hendrickson M, Mohle-Boetani J. Am J Epidemiol; 1988 Dec 19; 128(6):1216-27. PubMed ID: 3195563 [Abstract] [Full Text] [Related]
20. The Royal College of General Practitioners' Oral Contraception Study: some recent observations. Kay CR. Clin Obstet Gynaecol; 1984 Dec 19; 11(3):759-86. PubMed ID: 6509858 [Abstract] [Full Text] [Related] Page: [Next] [New Search]